PTPA and hepatoblastoma: Therefore, there is evidence that the PP2A environment may be dysregulated in poor prognosis hepatoblastoma, and FTY720 may have a significant impact on poor prognosis hepatoblastoma tumors through targeting both the Plk1 axis and the Wnt/beta-catenin pathway via effects on PP2A.